US Patent

US11730725 — Niraparib formulations

Formulation · Assigned to Tesaro Inc · Expires 2039-01-25 · 13y remaining

Vulnerability score 50/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects pharmaceutical tablet compositions containing the compound niraparib, suitable for oral administration, and methods for their preparation.

USPTO Abstract

The present invention relates to pharmaceutical tablet compositions comprising the compound niraparib as an active pharmaceutical ingredient, suitable for oral administration as well as to methods for their preparation. Also described herein are tablet compositions containing niraparib formed by the disclosed methods, and therapeutic uses of such tablet compositions for treating various disorders and conditions.

Drugs covered by this patent

Patent Metadata

Patent number
US11730725
Jurisdiction
US
Classification
Formulation
Expires
2039-01-25
Drug substance claim
No
Drug product claim
Yes
Assignee
Tesaro Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.